CIK 0001678660
- Non-accelerated filer
- Smaller reporting company
Prelude Therapeutics Inc
Sign in to watch- Ticker
- PRLD
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 811384762
- Phone
- +1 302-467-1280
- Business address
- 175 INNOVATION BOULEVARD, WILMINGTON, DE, 19805
- Former names
- Prelude Therapeutics Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-07-27 | Scherle Peggy Chief Scientific Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −20,000 | 36,460 | ||
| 2021-07-20 | Scherle Peggy Chief Scientific Officer | Grant or award · Employee Stock Option (Right to Buy) | +95,000 | 95,000 | ||
| 2021-07-20 | Vaddi Krishna President, CEO | Grant or award · Employee Stock Option (Right to Buy) | +285,800 | 285,800 | ||
| 2021-07-20 | Morosini Deborah EVP, Chief of Clinical Affairs | Grant or award · Employee Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2021-07-20 | Mauro David J Chief Medical Officer | Grant or award · Employee Stock Option (Right to Buy) | +95,000 | 95,000 | ||
| 2021-07-20 | Pierce Christopher EVP and Chief of Business Oper | Grant or award · Employee Stock Option (Right to Buy) | +85,000 | 85,000 | ||
| 2021-07-20 | Piper Brian Chief Financial Officer | Grant or award · Employee Stock Option (Right to Buy) | +115,650 | 115,650 | ||
| 2021-07-20 | Combs Andrew EVP, Head of Chemistry | Grant or award · Employee Stock Option (Right to Buy) | +95,000 | 95,000 | ||
| 2021-07-19 | Babler Martin Director | Grant or award · Employee Stock Option (Right to Buy) | +36,400 | 36,400 | ||
| 2021-07-06 | Mauro David J Chief Medical Officer | Exercise or conversion | +15,000 | $1.89 | $28K | 15,000 |
| 2021-07-06 | Mauro David J Chief Medical Officer | Sale | −10,445 | $27.17 | $284K | 4,555 |
| 2021-07-06 | Mauro David J Chief Medical Officer | Sale | −4,255 | $28.13 | $120K | 300 |
| 2021-07-06 | Mauro David J Chief Medical Officer | Sale | −300 | $28.84 | $9K | 0 |
| 2021-07-06 | Mauro David J Chief Medical Officer | Exercise or conversion · Employee Stock Option (Right to Buy) | −15,000 | 182,610 | ||
| 2021-06-18 | BAKER BROS. ADVISORS LP Director | Grant or award · Non-Qualified Stock Options (right to buy) | +23,344 | 23,344 | ||
| 2021-06-18 | Sandor Victor Director | Grant or award · Director Stock Option (Right to Buy) | +23,344 | 23,344 | ||
| 2021-06-18 | FRIEDMAN PAUL A Director | Grant or award · Director Stock Option (Right to Buy) | +23,344 | 23,344 | ||
| 2021-06-18 | Dier Mardi Director | Grant or award · Director Stock Option (Right to Buy) | +23,344 | 23,344 | ||
| 2021-06-18 | Bonita David P Director | Grant or award · Director Stock Option (Right to Buy) | +23,344 | 23,344 | ||
| 2021-06-07 | Mauro David J Chief Medical Officer | Exercise or conversion | +15,000 | $1.89 | $28K | 15,000 |
Page 11 of 19 · 369 trades